Subscribe to MDT Magazine News

Glenveigh Medical and Monica Healthcare Announce Distribution Agreement for Groundbreaking FDA Cleared Wireless Fetal Monitoring System

February 28, 2011 8:35 am | by Bio-Medicine.Org | Comments

CHATTANOOGA, Tenn., Feb. 28, 2011 /- Glenveigh Medical, LLC and Monica Healthcare Limited today announced an agreement for exclusive distribution rights in the United States as well as US territories and military bases for Monica Healthcare's AN24 wireless fetal monitoring system. The...


caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology

February 28, 2011 8:34 am | by Bio-Medicine.Org | Comments

BERLIN, and BURLINGTON, Mass., Feb. 28, 2011 /- caprotec bioanalytics GmbH announced today that the European Patent Office has granted the last of three core patents protecting its proprietary and revolutionary Capture Compound Mass Spectrometry (CCMS) technology.   CCMS offers a...


Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature

February 28, 2011 8:33 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Feb. 28, 2011 /- The Coalition for Ethical Imaging (CEI), a grassroots coalition with the goal of improving diagnostic imaging practices in Texas, is supporting House Bill 1809, sponsored by Representative Senfronia Thompson. The bill includes several initiatives that will...


Study comparing tenofovir gel and oral tablet finds gel provides more drug to tissue

February 28, 2011 5:39 am | by EurekAlert | Comments

(Microbicide Trials Network) In the first head-to-head study of tenofovir gel and oral tenofovir -- two promising approaches for preventing HIV in women -- researchers found daily use of the vaginal gel achieved a more than 100-times higher concentration of active drug in vaginal...


Cardiorobotics collects $6.5M in new funding

February 28, 2011 5:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Raynham-based Cardiorobotics Inc. has raised $6.5 million of a planned $12.5 million funding round, composed of equity and options-based securities, according to federal documents.

AACR to Host U.S. Surgeon General at Congressional Briefing on America's Continuing Tobacco Problem

February 28, 2011 5:35 am | by AACR | Comments

WASHINGTON, D.C. - U.S. Surgeon General Regina M. Benjamin, M.D., M.B.A., will discuss the dangers of tobacco use and her office's recently released report on smoking at an American Association for Cancer Research-sponsored congressional briefing on Tuesday, March 1, 2011.


Allon Therapeutics to Present Live, Online at on March 3rd

February 28, 2011 4:35 am | by Bio-Medicine.Org | Comments

VANCOUVER, British Columbia, Feb. 28, 2011 /- Allon Therapeutics Inc. (TSX: NPC), today announced that Gordon C. McCauley, President and CEO, will present at March 3rd, 2011TIME: 3:00 PM ESTLINK: This will be a live,...


WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors

February 28, 2011 4:33 am | by Bio-Medicine.Org | Comments

FREMONT, Calif., Feb. 28, 2011 /- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ), a leading developer of state-of-the-art genomic analysis systems, today announced that industry leader Dr. Timothy J. Triche, Professor of Pathology and Pediatrics at the University of Southern...


Heska to Present Live, Online at

February 28, 2011 4:33 am | by Bio-Medicine.Org | Comments

LOVELAND, Colo., Feb. 28, 2011 /- Heska Corporation (Nasdaq: HSKA ; "Heska" or the "Company") today announced it will present at on Thursday, March 3rd, 2011.  The company's presentation is scheduled to begin at 11:00 a.m. Eastern Time (9:00 a.m....


PDL BioPharma settles legal dispute with Novartis

February 28, 2011 3:45 am | by The Associated Press | Comments

Drug developer PDL BioPharma Inc. said Monday it has agreed to settle a legal dispute with Novartis under which it will pay the Swiss drugmaker an amount based on the net sales of the eye drug Lucentis made by Novartis this year and beyond.The settlement resolves all disputes between the...

Varian Medical Systems Announces New $280 Million Accelerated Stock Repurchase

February 28, 2011 3:37 am | by Bio-Medicine.Org | Comments

PALO ALTO, Calif., Feb. 28, 2011 /- Varian Medical Systems, Inc. (NYSE: VAR ) today announced that it has entered into a new agreement with Bank of America N.A. to repurchase $280 million of its common stock under an accelerated share repurchase program.   Under the accelerated...


SinoFresh Healthcare, Inc. Takes Groundbreaking Products to Europe

February 28, 2011 3:36 am | by Bio-Medicine.Org | Comments

VENICE, Fla., Feb. 28, 2011 /- SinoFresh® HealthCare, Inc., (Pink Sheets: SFSH ) announced today that its Senior Management Team has initiated a program to launch SinoFresh products in international markets. This would more than double the potential size of the market in the United...


Omni Bio Pharmaceutical Intends to Expand Type 1 Diabetes Trial to 50 Patients

February 28, 2011 3:35 am | by Bio-Medicine.Org | Comments

DENVER, Feb. 28, 2011 /- (OTC Bulletin Board: OMBP ) Omni Bio Pharmaceutical, Inc. ("Omni Bio"), an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase...


Intuity Medical Secures $20M Credit Facility From Silicon Valley Bank and Oxford Finance Corporation

February 28, 2011 3:35 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Feb. 28, 2011 /PRNewswire/ -- Intuity Medical, Inc .™, a privately-held company developing innovative technologies in diabetes management, announced that it has secured a $20M credit facility from Silicon Valley Bank and Oxford Finance Corporation . The funds will...


OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference

February 28, 2011 3:34 am | by Bio-Medicine.Org | Comments

BOTHELL, Wash., and VANCOUVER, British Columbia, Feb. 28, 2011 /- OncoGenex Pharmaceuticals, Inc. (Nasdaq: OGXI ) announced today that Scott Cormack, OncoGenex's president and chief executive officer, will take part in a panel discussion on novel cancer treatments at the upcoming RBC...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.